Matches in Wikidata for { <http://www.wikidata.org/entity/Q73042497> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q73042497 description "article scientifique publié en 1999" @default.
- Q73042497 description "artículu científicu espublizáu n'ochobre de 1999" @default.
- Q73042497 description "im Oktober 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73042497 description "scientific article published on 01 October 1999" @default.
- Q73042497 description "wetenschappelijk artikel" @default.
- Q73042497 description "наукова стаття, опублікована в жовтні 1999" @default.
- Q73042497 name "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 name "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 type Item @default.
- Q73042497 label "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 label "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 prefLabel "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 prefLabel "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 P1433 Q73042497-78267F7C-4C77-4366-97F8-1ED8316164E6 @default.
- Q73042497 P1476 Q73042497-70524DA8-978E-45C4-B673-FEEB64D100C0 @default.
- Q73042497 P2093 Q73042497-0B84C379-8806-4D67-A09B-51011038135D @default.
- Q73042497 P2093 Q73042497-2200FDAF-32C2-46C9-8D26-933BD5E2024B @default.
- Q73042497 P2093 Q73042497-7E495D63-8BDE-41EF-84C3-822390FAC906 @default.
- Q73042497 P2093 Q73042497-A6E270A7-B1D9-4646-97E2-83442D2B31E8 @default.
- Q73042497 P2093 Q73042497-AFCC4491-945E-4F25-A7F5-080870D083B0 @default.
- Q73042497 P304 Q73042497-953790C6-C898-451A-A0B3-AC9597EFEEDA @default.
- Q73042497 P31 Q73042497-88150131-9BC9-48DE-9C4B-96E6257193F0 @default.
- Q73042497 P356 Q73042497-FED1FB94-5B3E-43ED-ABF2-E9F816875436 @default.
- Q73042497 P407 Q73042497-3544B804-09B9-4A40-86FE-E5C40584ABC9 @default.
- Q73042497 P433 Q73042497-DF8652DE-03CE-4409-91E9-67634B787399 @default.
- Q73042497 P478 Q73042497-9D459BF0-D10E-4D30-A773-1B57EBC5F152 @default.
- Q73042497 P577 Q73042497-ADFE3D1F-2D7E-4CED-B378-8851865A9542 @default.
- Q73042497 P698 Q73042497-661D66D6-0486-4055-BDC1-A3FB5607C385 @default.
- Q73042497 P921 Q73042497-6987E5C5-95BD-450F-B345-170FC854B149 @default.
- Q73042497 P921 Q73042497-8C9D2500-7B18-4B02-943C-C4E6606EEDB2 @default.
- Q73042497 P921 Q73042497-E79A8899-B242-486A-8859-243007E31E7F @default.
- Q73042497 P356 (SICI)1097-0142(19991001)86:7%3C1368::AID-CNCR37%3E3.0.CO;2-8 @default.
- Q73042497 P698 10506727 @default.
- Q73042497 P1433 Q326041 @default.
- Q73042497 P1476 "Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma" @default.
- Q73042497 P2093 "Akpek G" @default.
- Q73042497 P2093 "Bogen S" @default.
- Q73042497 P2093 "Foss FM" @default.
- Q73042497 P2093 "Koh HK" @default.
- Q73042497 P2093 "O'Hara C" @default.
- Q73042497 P304 "1368-1376" @default.
- Q73042497 P31 Q13442814 @default.
- Q73042497 P356 "10.1002/(SICI)1097-0142(19991001)86:7<1368::AID-CNCR37>3.0.CO;2-8" @default.
- Q73042497 P407 Q1860 @default.
- Q73042497 P433 "7" @default.
- Q73042497 P478 "86" @default.
- Q73042497 P577 "1999-10-01T00:00:00Z" @default.
- Q73042497 P698 "10506727" @default.
- Q73042497 P921 Q18936 @default.
- Q73042497 P921 Q418817 @default.
- Q73042497 P921 Q974135 @default.